Clinical Trials in Los Angeles

Showing 5801-5820 of 16,901 trials

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

NCT02873195

This randomized phase II trial studies how well capecitabine and bevacizumab with or without atezolizumab work in treating patients with colorectal cancer that is not responding to treatment and has spread to other places. Immunotherapy with monoclonal antibodies, such as atezolizumab and bevacizumab, may help the body?s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving atezolizumab with capecitabine and bevacizumab may be a better way in treating colorectal cancer.

Metastatic Colorectal CarcinomaRecurrent Colorectal CarcinomaRefractory Colorectal Carcinoma+3 more

Academic and Community Cancer Research United133 participantsStarted Jul 2017

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Duarte, California, United States +7 more locations

TERMINATEDPhase 2< 1 mile

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

NCT03976076

A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients.

Refractory Infantile Spasms

Bio-Pharm Solutions Co., Ltd.16 participantsStarted Apr 2020

Little Rock, Arkansas, United States • Los Angeles, California, United States • Los Angeles, California, United States +20 more locations

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients

Find Trials by Condition in Los Angeles

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)

Integrative Self-care Approaches for HCP Wellbeing

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

LEAPTogether: An Intergenerational Intervention to Address Loneliness and Social Isolation

A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)

A Clinical Trial to Evaluate the Effect of ConcenTrace Trace Mineral Drops on Gut Health

A Clinical Trial to Evaluate the Efficacy of ConcenTrace to Buffer pH Levels Within the Body.

A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products

Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement

A Single Group Study to Evaluate the Effects of a Probiotic Vaginal Suppository on Vaginal Health.

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy

Models of Nutrition From Continuous Glucose Monitors

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

Clinical Evaluation of the Infinity Deep Brain Stimulation System

A Study of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Diphtheria, Pertussis and Tetanus (Tdap) Viruses Followed by a 2nd Dose of the RSV Vaccine to Healthy Non-Pregnant Women